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SUMMARY: Immune system plays an important role in pathogenesis of diabetes (DM). Besides 
hypoglycaemics, rasayanas are indicated in the management of DM. In several studies the 
immunomodulatroy potentials of rasayanas have been proved. A clinical trial of three rasayana 
drugs, Asparagus recemosus  (AR). Bacopa monnieri (BM) and Centella asiatica (CA) was 
carried out in diabetics.  In this study, diabetics were found to have significantly lower levels of 
serum IgG, increased serum IgA and comparable levels of IgM. All drugs reverted levels of 
serum IgG levels in diabetics, however, statistical significance was attained only with AR. 
Further the increased IgA levels were brought back towards normal.  These drugs also increased 
serum protein levels. 
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INTRODUCTION: 
 
The incidence of Diabetes mellitus (DM) is 
rapidly increasing in urban population 
because of increased environmental risk 
factors like low physical activity, high 
calorie-intake, obesity and stress. At the 
same time , the rural and slum population 
continues to be affected with malunutrition 
related diabetes mellitus (MRDM).
(1) 
Immune system plays central role in the 
pathogenesis of DM and its complications.  
Patients of diabetes have a high incidence of 
organ specific auto antibodies and DM is 
associated clinically with several other 
autoimmune disorders.  There is an 
increased incidence of infections which are 
more severe and more protracted in 
diabetics.  Alterations in humoral l- and cell- 
mediated immunity and granulocyte 
functions leading to compromised host 
defence against a veriety of infectious agents 
have been described in patients and 
experimental models of diabetes. 
(2) Triola et 
al reported lower levels of IgG, higher levels 
of IgA and similar levels of IgM in diabetics 
s compared to healthy controls
(3). 
 
The Ayurvedic concept of madhumeha is 
similar to D.M. The Understanding of 
madhumeha in Ayurveda dates back to 1000 
B.C wherein, the role of diet, physical 
activity, obesity and genetics in the 
aetiopathogenesis and management of DM 
has been described. Along with 
hypoglycaemics diabetics were also 
prescribed rasayana herbs to prevent the 
complications. Rasayana therapy is used for 
promotion of health and to improve 
longevity along with physical and mental 
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strength 
(4,5) All these benefits are probably 
obtained by the promotion of ojas, a concept 
similar to the modern concept of immunity 
(6).  Madhumeha is characterized by loss of 
ojas, thus, along with hypoglycaemics, 
rasayanas are prescribed in madhumeha to 
improve the ojas and prevent the 
complication, Satavari and brahmi are two 
very important rasayanas mentioned in 
Ayurveda.  These drugs have been put to 
extensive experimental and clinical trials on 
modern parameters to prove their 
immunotherapeutic potentials, satavari is 
Asparagus racemosus (AR) of Liliaceae 
family, experimentally it has been found to 
protect animals against infections in normal 
and immunosuppressed status induced by 
hemisplenectomy or surgery 
(7) AR has been 
proved to be safe in both acute and subacute 
toxicity studies 
(8). There are two drugs 
known as Brahmi, one is Bacopa monnieri 
(Fam. Scrophulariacease, BM) and the other 
is Centella asiatica (Fam. Umbellifereae, 
CA).  In an experimental study, the aqueous 
suspension of CA was found to possess 
immunostimulant activity 60% of that of 
recombinant α – 2b interferon, 
(9) Extensive 
experimental studies have been conducted to 
evaluate the psychopharmacological effect 
of BM. 
(10) Considering the role played by 
immune system in pathophysiology of   
Ayurvedic rasayanas, this collaborative 
clinical study was conducted at Institute of 
Medical Sciences, Banaras Hindu 
University, Varanasi by the departments of 
Dravyaguna (Faculty of Ayurveda), 
Pharmacology and Immunopathology, to 
evaluate the immunomodulatory effects of 
rasayana drugs in diabetics. 
 
SUBJECTS  
 
Subjects of the study were chosen form 
Diabetes- clinic of Department of 
Dravyaguna, Institute of Medical Sciences, 
Banaras Hindu University, Varanasi.  The 
diabetics with more than thirty years of  age, 
of either sex with diagnosed NIDDM on 
more then 3 years duration  and not having 
any complications of diabetes were eligible 
to enter the study, Exclusion criteria are 
listed in the box.  Patients developing 
complications of diabetes or infections 
during the study period were not included in 
final analysis. Inpatients with uncontrolled 
blood sugar, the level of blood sugar was 
controlled and the doses  
 
Exclusion criteria 
1.  Pregancy 
2.  Patients with immune disorders 
3.  Other chronic diseases 
4.  Major surjory during last 6 months 
5.  Patients on drugs affecting immune 
system 
6.  Malnourished patients (BMI less 
than normal)   
   
of hypoglycaemic drugs were stabilized to 
avoid changes in dosage schedule during the 
trial.  The serum protein and serum 
immunoglobulins (LgG, IgA & IgM) 
(11) 
were assessed in the patients whose blood 
sugar has been controlled for one month.   
Thereafter, these patients were randomly 
assigned in four groups A, B C or D, thus, a 
patient was receving the extract of either AR 
or BM or CA or simply placebo. 
 
DRUGS 
 
On the basis of Ayurvedic literature and 
experimental and clinical studies on modern 
scientific parameters, we chose shatavari 
(Asparagus racemosus, fam. Liliaceae) and 
two brahmis, viz. Bacopa monnieri, of 
scrophulariaceae family and centella asiatica 
of Umbelliferae.  The plants were collected 
from the Ayurvedic garden of the Institute 
keeping in mind season soil and dried in 
shade as prescribed in Ayurveda. The 
ghanasattva (solid water extract) was 
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prepared from the whole plant.  The extract 
was encapsulated to ensure blinding, 
uniformity of administration and for 
convenience of patients.  One capsule 
contained 500 mg of the extract.  Each drug 
was administered in the dose of 500 mg 
orally once a day (fixed dose) for a period of 
about a weeks, 2 hours after food or 1 hour 
before food to prevent any interference with 
its absorption. 
 
RESULTS  
 
The distribution of the patients in the study 
with respect to their age and duration of 
diabetes is shown in table 1.  All the four 
groups were comparable with respect to the 
age and duration of diabetes. 
 
This study shows what NIDDM Patients 
have statistically significant decreased 
serum IgG and increased serum IgA levels 
when compared to health controls However, 
no significant difference was found in serum 
IgM levels (Table 2) After 4 weeks of 
treatment with the rasayana drugs, the IgG 
levels increased in all the treatment groups.  
However, this rise was significant only in 
patients treated with AR. In the placebo 
group, there was a non-significant decrease 
in serum IgG levels.  Serum IgA levels were 
significantly decreases in AR treated group. 
In BM and CA groups. There was a decrease 
in IGA levels.  Which was statically non-
significant.  On the other had. IgA levels 
were found to be slightly raised in placebo 
group after 4 weeks. 
 
No appreciable change was seen in serum 
1gM levels in either group. S.protein as 
raised in all the 4 groups.  Maximal rise was 
seen in AR treated group. But in none of the 
groups. It reached the significance leavel 
(Table3). 
 
DISCUSSION 
 
Diabetes mellitus is also associated with 
disturbances in the immune system as levels 
of immunoglobulins are reported to be 
altered.  This shows that even patients with 
noncomplicated diabetes have raided levels 
of IgA . deceased levels of IgG and normal 
IgM in serum.  This is inconformity with 
earlier studies and these play an important 
role in the progression of disease and 
development of  complications. (3&12) 
Immune mediated beta cell destruction is 
one of the important factors in the 
development of DM.  The usefulness of 
immunomodulators in the treatment of 
initial phases of DM has been well 
established. 
(13) Stress precipitates DM and 
has a significant role in the progression.   
Infection prone diabetic patient is caught in 
the vicious cycle. 
 
The role of immune system in the 
pathogenesis of madhumeha is also well 
appreciated in Ayurveda and the disease is 
known as ojomeha i.e the one characterized 
b deranged immune system.  Rasayanas are 
particularly important in the ayurvedic 
management of DM.  Rasayanas either 
directly act on immune system or can act on 
psycho-neuro –immune (PNI) axis to 
regulate immnue functions
.(14)  Experiments 
have reliably documented the effect of stress 
on immune function and existence of 
unsuspected connections between the 
nervous and immune system 
(15).  Several 
rasayana drugs including AR have shown 
antistress activities in experimental studies. 
(16) There man subtypes of Rasayanas and 
therapy can be individualised according to 
personality traits and requirement, e.g., 
ojovardhaka (immunomodulators Ramayana 
will be particularly useful in diseases 
involving of immune system like diabetes 
and medhya rasayana can be useful in 
mitigating the stress associated effects. 
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This study on rasayanas shows that AR, as 
mentioned predominantly balya drugs, is 
more effective in immune regulation. These 
effects may partly be due to modulation of 
the PNI axis as a result of antistress 
activity
(16)Other drugs used, BM and CA, 
belonging to medhya to medhya rayasana 
group acting mainly on CNS
(10) did produce 
effect on immune system, however, 
significance level could not be achieved. 
Thus, balya rasayana drug, AR, acts mainly 
on the immune system and this is 
conformity with the ayurvedic concept of 
balya drugs. 
 
This study clearly shows of AR on immune 
system, however, to assess the long term 
significance of the same and the 
mechanisms involved therein, further 
largescale studies of prolonged duration 
including more parameters are reuired.   
Advantages of safety, easy availability and 
low cost of herbs will always be there. 
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Table -1 
Distribution of patients in the study with respect to their age and duration of diabetes 
 
Age (year)  TOTAL No of 
Patients 
(N=40) 
Placebo 
(n=12) 
AR 
(n=11) 
BM 
(n=9) 
CA 
(n=8) 
34-40 
 
41-50 
 
51-60 
 
>60 
6(15%) 
 
24(60%) 
 
9(23%) 
 
1(2%) 
2(17%) 
 
7(58%) 
 
2(17%) 
 
1(8%) 
2(18%) 
 
7(55%) 
 
3(27%) 
 
2(22%) 
 
5(56%) 
 
2(22%) 
2(25%) 
 
5(62%) 
 
1(13%) 
Duration of Diabetes 
3-6 years 
 
7-10 years 
 
11-14 years 
 
>14 years 
14(35%) 
 
15(37.5%) 
 
8(20%) 
 
3(7.5%) 
4(33%) 
 
5(42%) 
 
2(17%) 
 
1(8%) 
4(36%) 
 
4(36%) 
 
2(18%) 
 
1(9%) 
 
3(33%) 
 
3(33%) 
 
2(22%) 
 
1(9%) 
3(37.5%) 
 
3(37.5%) 
 
2(25%) 
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Table -2 
Basal levels of Immunoglobulins in Diabetics and Health Adults 
 
 IgG  IgA  IgM 
Diabetics (n=40) 
 
Health volunteers 
(n=10) 
993.75* ± 150.29 
 
1145.50 ± 168.20 
345** ± 34.42 
 
95.50 ± 40.90 
143.50 ± 41.23 
 
148.70 ± 40.90 
 
Values are expressed as Mean ± S.D. 
*P<0.05 
**P<0.01 
 
Table -3 
Effects of Rasayana Drugs on Serum Protein (g/dl) and Immunoglobulin (mg/dl) levels in diabetes 
 
Serum IgG levels 
 Placebo   
(n=12) 
AR 
(n=11) 
BM 
(n=9) 
CA  
(n=8) 
Pretreatment 
 
Post treatment 
979.17 ± 137.28 
 
975 ± 140.6 
963.64± 132.46 
 
1104.5± 129.33* 
1027.8 ± 167.9 
 
1061.1±140.93 
1018.75±186.9 
 
1050± 110.19 
Serum IgA levels 
Pretreatment 
 
Post treatment 
345.8±35.8 
 
345.17±41.67 
345.45±37.5 
 
281.8±60.14* 
344.4 ± 33.58 
 
328.89±40.76 
343.75±35.8 
 
322.5±30.12 
Serum IgM levels 
Pretreatment 
 
Post treatment 
146.67±32.0 
 
144.17±37.28 
148.18±48.54 
 
146.36±39.06 
138.89±40.76 
 
142.22±30.73 
137.5±49.79 
 
146.25±46.58 
Serum Protein levels 
Pretreatment 
 
Post treatment 
6.25±1.1 
 
6.34±0.98 
6.175±0.98 
 
6.65±0.7 
6.28±096 
 
6.36±0.86 
6.21±1.03 
 
6.38±0.96 
 
 Values are expressed as Mean ± S.D. 
*P<0.05 
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